CG Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

CG Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$310K	Sell	4,897 -14,123	-74%	-$891K	0.12%	115
2016 Q3	$1.21M	Sell	19,020 -14,082	-43%	-$1.03M	0.45%	65
2016 Q2	$2.46M	Buy	33,102 +22,666	+217%	+$1.68M	0.99%	37
2016 Q1	$697K	Buy	+10,436	New	+$634K	0.28%	81
2014 Q3	–	Sell	-44,644	Closed	-$1.74M	–	134
2014 Q2	$1.74M	Sell	44,644 -11,012	-20%	-$447K	0.73%	53
2014 Q1	$2.34M	Buy	55,656 +3,078	+6%	+$128K	1.05%	35
2013 Q4	$1.73M	Buy	+52,578	New	+$1.71M	0.79%	46

Other funds holding LGND

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CG Asset Management's LGND Position: Q4 2016 in Review

CG Asset Management reduced its Ligand Pharmaceuticals (LGND) stake by 74% in Q4 2016, selling an estimated $891K and leaving 4,897 shares worth $310K. The position accounts for 0.12% of the portfolio, ranked #115.

CG Asset Management first reported a position in LGND in Q4 2013 and has held it in 7 quarters since. The position peaked at $2.46M in Q2 2016. 269 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

CG Asset Management held 4,897 shares of Ligand Pharmaceuticals worth $310K as of Q4 2016.
CG Asset Management sold 14,123 Ligand Pharmaceuticals shares in Q4 2016, an estimated $891K.
Ligand Pharmaceuticals made up 0.12% of CG Asset Management's portfolio in Q4 2016, its #115 holding.
CG Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 7 quarters since.
CG Asset Management's Ligand Pharmaceuticals position peaked at $2.46M in Q2 2016.
269 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.